Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats

Psychopharmacology

Volumn 225, Issue 2, 2013, Pages 275-281

  Zalewska Kaszubska, Jadwiga ^a   Bajer, Bartosz ^a   Gorska, Dorota ^a   Andrzejczak, Dariusz ^a   Dyr, Wanda ^b   Bieńkowski, Przemysław ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Alcohol; Beta endorphin; Topiramate; Warsaw high preferring rats

Indexed keywords

BETA ENDORPHIN; TOPIRAMATE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; FLUID INTAKE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ANTICONVULSANTS; BETA-ENDORPHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; FRUCTOSE; RATS; TIME FACTORS;

EID: 84872293433     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2812-z     Document Type: Article

References (36)

1. Angehagen M, Ben-Menachem E, Shank R, Ronnback L, Hansson E (2004) Topiramate modulation of kainite-induced calcium currents is inversely related to channel phosphorylation level. J Neurochem 88:320-325
2. Angehagen M, Ronnback L, Hansson E, Ben-Menachem E (2005) Topiramate reduces AMPA-induced Ca(2+)transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 94:1124-1130
3. Baltieri DA, Daró FR, Ribeiro PL, de Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035-2044
4. Breslin FJ, Johnson BA, Lynch WJ (2010) Effect of topiramate treatment on ethanol consumption in rats. Psychopharmacology (Berl) 207:529-534
5. Cagetti E, Baicy KJ, Olsen RW (2004) Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. Neuroreport 15:207-210
6. Chiu YH, Lee TH, Shen WW (2007) Use of low-dose topiramate in substance use disorder and body weight control. Psychiatry Clin Neurosci 6:630-633
7. Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(Suppl 1):S35-S39
8. Dyr W, Kostowski W (2008) Warsaw high-preferring (WHP) and Warsaw low-preferring (WLP) lines of rats selectively bred for high and low voluntary ethanol intake: preliminary phenotypic characterization. Alcohol 42:161-170
9. Farook JM, Morrell DJ, Lewis B, Littleton JM, Barron S (2007) Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice. Alcohol Alcohol 42:296-300
10. Farook JM, Lewis B, Littleton JM, Barron S (2009) Topiramate attenuates the stress-induced increase in alcohol consumption and preference in male C57BL/6J mice. Physiol Behav 96:189-193
11. Flórez G, García-Portilla P, Alvarez S, Saiz PA, Nogueiras L, Bobes J (2008) Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcohol Clin Exp Res 32:1251-1259
12. Flórez G, Saiz PA, García-Portilla P, Alvarez S, Nogueiras L, Bobes J (2011) Topiramate for the treatment of alcohol dependence: comparison with naltrexone. Eur Addict Res 17:29-36
13. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24:4412-4420
14. Gabriel KI, Cunningham CL (2005) Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice. Alcohol Clin Exp Res 29:75-80
15. Gianoulakis C, Beliveau D, Angelogianni P, Meaney M, Thavundayil J, Tawar V, Dumas M (1989) Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 45:1097-1109
16. Gremel CM, Gabriel KI, Cunningham CL (2006) Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or C57BL/6J mice. Alcohol Clin Exp Res 30:783-790
17. Gryder DS, Rogawski MA (2003) Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdale neurons. J Neurosci 23:7069-7074
18. Hargreaves GA, McGregor IS (2007) Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res 31:1900-1907
19. Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ (2004) Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61:905-912
20. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641-1651
21. Kiefer F, Wiedemann K (2004) Neuroendocrine pathways of addictive behaviour. Addict Biol 9:205-212
22. Kiefer F, Horntrich M, Jahn H, Wiedemann K (2002) Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Psychopharmacology 162:433-437
23. Kiefer F, Jahn H, Otte C, Nakovics H, Wiedemann K (2006) Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference. Neurosci Lett 404:103-106
24. Lynch WJ, Bond C, Breslin FJ, Johnson BA (2011) Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse. Psychopharmacology (Berlin) 217:3-12
25. Miranda R Jr, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J (2008) Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res 32:489-497
26. Nguyen SA, Malcolm R, Middaugh LD (2007) Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse 6:150-156
27. Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I (2011) Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. BMC Psychiatry 11:41
28. Rustembegovic A, Sofic E, Kroyer G (2002) A pilot study of Topiramate (Topamax) in the treatment of tonic-clonic seizures of alcohol withdrawal syndromes. Med Arh 56:211-212
29. Van Ree JM (1996) Endorphins and experimental addiction. Alcohol 13:25-30
30. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH (2000) Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41(Suppl 1):S17-S20
31. Zalewska-Kaszubska J, Czarnecka E (2005) Deficit in beta-endorphin peptide and tendency to alcohol abuse. Peptides 26:701-705
32. Zalewska-Kaszubska J, Cwiek W, Dyr W, Czarnecka E (2005) Changes in the beta endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference. Neurosci Lett 388:45-48
33. Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E (2007) Effect of repeated treatment with topiramate on the beta-endorphin plasma level in rats selectively bred for high and low alcohol preference. Prog Neuropsychopharmacol Biol Psychiatry 31:525-528
34. Zalewska-Kaszubska J, Górska D, Dyr W, Czarnecka E (2008a) Lack of changes in beta-endorphin plasma levels after repeated treatment with fluoxetine: possible implications for the treatment of alcoholism - a pilot study. Pharmazie 63:308-311
35. Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E (2008b) Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone. Physiol Behav 93:1005-1010
36. Zona C, Ciotti MT, Avoli M (1997) Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett 231:123-126